Intervention

Tc 99m tilmanocept

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

3 shown

Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RANCT04078191 · 2021-09-14

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar ImagingNCT03938636 · 2019-04-08

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node BiopsyNCT03199560 · 2017-06-22

Common conditions

Rheumatoid Arthritis2 Breast Cancer1 Sentinel Lymph Node Biopsy1

Leading sponsors

Navidea Biopharmaceuticals2 Memorial Health University Medical Center1

Trial status mix

COMPLETED1

TERMINATED1

UNKNOWN1

Phase mix

PHASE22

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.